SCHEMBL31201698

SCHEMBL31201698

CC(O)c1ccc2nc(Cl)ccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.52
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
KCNH2 Q12809 1/20 0.38
PDE2A O00408 1/20 0.38
PDE10A Q9Y233 1/20 0.38
PLAU P00749 2/20 0.37
PIK3CD O00329 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
HCK P08631 1/20 0.37
SRC P12931 1/20 0.37
KDR P35968 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15447380 0.87 UGT2B7 (0.48) UGT2B7CYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL3976029 0.85 NPC1 (0.42) UGT2B7CYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL14269818 0.82 NMT1 (0.38) UGT2B7CYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL31091858 0.81 TRPV4 (0.37) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL31201745 0.80 CYP1A2 (0.55) UGT2B7PDE2APDE10APLAUPLG
SCHEMBL21800896 0.79 SCN10A (0.42) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL3934374 0.78 NMT1 (0.37) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL11832003 0.76 UGT2B7 (0.49) UGT2B7PLAUPLGSCN9ACYP1A2
SCHEMBL5610446 0.76 UGT2B7 (0.82) UGT2B7CYP2D6PLAUPLGKMT2A
SCHEMBL9899041 0.74 UGT2B7 (0.50) UGT2B7CYP3A4CYP2D6SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed